Clinical: N/ADemographic: AgePathological: clinical stage, expression of ER, PR, HER2, and Ki-67, immunohistochemical regimen, and type of surgery.Radiomics: tumor size and volume, Parametric Response Map (PRM), and pharmacokinetic parameters (Ktrans, Kep, and Ve). The gene discussed is ERBB2; the disease is neoplasm.